393 related articles for article (PubMed ID: 14960151)
1. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis.
Ikeda H; Nishi S; Sakai M
Biochem J; 2004 Jun; 380(Pt 2):515-21. PubMed ID: 14960151
[TBL] [Abstract][Full Text] [Related]
2. CCAAT enhancer-binding protein alpha suppresses the rat placental glutathione S-transferase gene in normal liver.
Ikeda H; Omoteyama K; Yoshida K; Nishi S; Sakai M
J Biol Chem; 2006 Mar; 281(10):6734-41. PubMed ID: 16407263
[TBL] [Abstract][Full Text] [Related]
3. Activation of glutathione transferase P gene by lead requires glutathione transferase P enhancer I.
Suzuki T; Morimura S; Diccianni MB; Yamada R; Hochi S; Hirabayashi M; Yuki A; Nomura K; Kitagawa T; Imagawa M; Muramatsu M
J Biol Chem; 1996 Jan; 271(3):1626-32. PubMed ID: 8576162
[TBL] [Abstract][Full Text] [Related]
4. Regulation of GST-P gene expression during hepatocarcinogenesis.
Sakai M; Muramatsu M
Methods Enzymol; 2005; 401():42-61. PubMed ID: 16399378
[TBL] [Abstract][Full Text] [Related]
5. Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis.
Ohta K; Ohigashi M; Naganawa A; Ikeda H; Sakai M; Nishikawa J; Imagawa M; Osada S; Nishihara T
Biochem J; 2007 Mar; 402(3):559-66. PubMed ID: 17083329
[TBL] [Abstract][Full Text] [Related]
6. Regulation of glutathione transferase P: a tumor marker of hepatocarcinogenesis.
Sakai M; Muramatsu M
Biochem Biophys Res Commun; 2007 Jun; 357(3):575-8. PubMed ID: 17434454
[TBL] [Abstract][Full Text] [Related]
7. Activation of mouse Pi-class glutathione S-transferase gene by Nrf2(NF-E2-related factor 2) and androgen.
Ikeda H; Serria MS; Kakizaki I; Hatayama I; Satoh K; Tsuchida S; Muramatsu M; Nishi S; Sakai M
Biochem J; 2002 Jun; 364(Pt 2):563-70. PubMed ID: 12023900
[TBL] [Abstract][Full Text] [Related]
8. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
McMahon M; Itoh K; Yamamoto M; Chanas SA; Henderson CJ; McLellan LI; Wolf CR; Cavin C; Hayes JD
Cancer Res; 2001 Apr; 61(8):3299-307. PubMed ID: 11309284
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
10. Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione.
Kwak MK; Itoh K; Yamamoto M; Sutter TR; Kensler TW
Mol Med; 2001 Feb; 7(2):135-45. PubMed ID: 11471548
[TBL] [Abstract][Full Text] [Related]
11. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
12. Development of glutathione S-transferase-P-negative foci accompanying nuclear factor-erythroid 2-related factor 2 expression during early stage of rat hepatocarcinogenesis.
Fan Y; Shimizu T; Yamada T; Nanashima N; Akita M; Asano J; Tsuchida S
Cancer Sci; 2008 Mar; 99(3):497-501. PubMed ID: 18081878
[TBL] [Abstract][Full Text] [Related]
13. Selective induction of the tumor marker glutathione S-transferase P1 by proteasome inhibitors.
Usami H; Kusano Y; Kumagai T; Osada S; Itoh K; Kobayashi A; Yamamoto M; Uchida K
J Biol Chem; 2005 Jul; 280(26):25267-76. PubMed ID: 15863507
[TBL] [Abstract][Full Text] [Related]
14. Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 activation: the role in glutathione S-transferase A2 gene repression.
Park IN; Cho IJ; Kim SG
Drug Metab Dispos; 2004 Sep; 32(9):893-7. PubMed ID: 15319326
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
Ki SH; Cho IJ; Choi DW; Kim SG
Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
[TBL] [Abstract][Full Text] [Related]
16. [Regulation mechanism of specific expression of tumor marker gene during carcinogenesis].
Imagawa M
Yakugaku Zasshi; 1996 Jul; 116(7):505-18. PubMed ID: 8831256
[TBL] [Abstract][Full Text] [Related]
17. Ceramide negatively regulates glutathione S-transferase gene transactivation via repression of hepatic nuclear factor-1 that is degraded by the ubiquitin proteasome system.
Park IN; Cho IJ; Kim SG
Mol Pharmacol; 2004 Jun; 65(6):1475-84. PubMed ID: 15155840
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis.
Osada S; Suzuki S; Yoshimi C; Matsumoto M; Shirai T; Takahashi S; Imagawa M
Oncol Rep; 2013 Oct; 30(4):1669-74. PubMed ID: 23912631
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase A4 is a positive marker for rat hepatic foci induced by clofibrate and genotoxic carcinogens.
Shimizu T; Fan Y; Yamana D; Miura T; Nanashima N; Yamada T; Tsuchida S
Cancer Sci; 2010 May; 101(5):1093-8. PubMed ID: 20180811
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1.
Nguyen T; Sherratt PJ; Nioi P; Yang CS; Pickett CB
J Biol Chem; 2005 Sep; 280(37):32485-92. PubMed ID: 16000310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
